Position in ABBV
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$10,949,862
+$1,744,163 QoQ
Shares Held
43,514
+2.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#882
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST CITIZENS BANK & TRUST CO holds $87,047,230 across 11 Drug Manufacturers - General names. ABBV ranks #2 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
31,493 | $37,773,651 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
43,514 | $10,949,862 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
73,799 | $9,323,765 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,055 | $8,231,067 | |
| 5 | JNJ |
Johnson & Johnson
|
30,811 | $7,825,069 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
94,434 | $5,441,286 | |
| 7 | AMGN |
Amgen Inc
|
9,717 | $3,518,719 | |
| 8 | PFE |
Pfizer Inc
|
79,991 | $1,926,182 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,949,862 | 43,514 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $9,205,699 | 42,327 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $7,760,662 | 33,965 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $8,065,463 | 34,834 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $6,917,500 | 37,267 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $8,565,386 | 40,881 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $7,265,619 | 40,887 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $8,376,311 | 42,416 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $7,382,220 | 43,040 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $7,648,564 | 42,002 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $914,632 | 5,902 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $863,652 | 5,794 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $849,068 | 6,302 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $996,380 | 6,252 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,905,747 | 17,980 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $3,578,709 | 26,665 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $3,154,330 | 20,595 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $4,012,707 | 24,753 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $3,167,818 | 23,396 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $1,837,133 | 17,031 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $1,996,994 | 17,729 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $1,924,476 | 17,783 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $4,052,948 | 37,825 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $3,718,020 | 42,448 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $3,722,003 | 37,910 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $993,517 | 13,040 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||